Skip to main content
SpringerLink
Log in

Schizophrenia and Its Sequelae

  • Chapter
  • First Online:
Beyond Assessment of Quality of Life in Schizophrenia

  • 1082 Accesses

Abstract

Background: Schizophrenia is considered to be one of the most serious of mental illnesses in terms of the patient, the patient’s family, and the patient’s community.

Aim: The aim of this chapter is to introduce the reader into the realities of life with schizophrenia.

Method: The literature on schizophrenia is vast and cannot be easily reviewed. Topics relevant to quality of life in schizophrenia were first determined via consultation with clinicians, researchers, and experts by experience. The most pertinent and up-to-date references were then selected and summarized.

Results: Schizophrenia, its risk factors, demographics, life course, sequelae, and treatment all point to many interactive factors that can, and do, undermine both subjective and objective quality of life.

Conclusion: The purpose of researching quality of life issues in schizophrenia is to better understand how best to intervene clinically and how best to help patients with this diagnosis meet their life goals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry. 2010;2:417–28.

    Article  Google Scholar 

  • American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

    Google Scholar 

  • Bach P, Hayes SC. The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol. 2002;70:1129–39.

    Article  PubMed  Google Scholar 

  • Barker V, Gumley A, Schwannauer M, Lawrie SM. An integrated biopsychosocial model of childhood maltreatment and psychosis. Br J Psychiatry. 2015;206:177–80.

    Article  PubMed  Google Scholar 

  • Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr Bull. 2013;39:1242–51.

    Article  PubMed  PubMed Central  Google Scholar 

  • Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O’Brien R, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry. 2001;158:1706–13.

    Article  CAS  PubMed  Google Scholar 

  • Bengtsson-Tops A, Ehliasson K. Victimization in individuals suffering from psychosis: a swedish cross-sectional study. J Psychiatr Ment Health Nurs. 2012;19:23–30.

    Article  CAS  PubMed  Google Scholar 

  • Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012;1262:56–66.

    Article  PubMed  Google Scholar 

  • Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry. 2014;75:324–31.

    Article  CAS  PubMed  Google Scholar 

  • Bond GR, Drake RE, Becker DR. An update on randomized controlled trials of evidence-based supported employment. Psychiatr Rehabil J. 2008;31:280–90.

    Article  PubMed  Google Scholar 

  • Braga RJ, Reynolds GP, Siris SG. Anxiety comorbidity in schizophrenia. Psychiatry Res. 2013;210:1–7.

    Article  PubMed  Google Scholar 

  • Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P. Suicide in schizophrenia. Expert Rev Neurother. 2010;10:1153–64.

    Article  PubMed  Google Scholar 

  • Charrier N, Chevreul K, Durand-Zaleski I. The cost of schizophrenia: a literature review. Encéphale. 2013;39 Suppl 1:S49–56.

    Article  PubMed  Google Scholar 

  • Cichocki Ł, Cechnicki A, Franczyk-Glita J, Błądziński P, Kalisz A, Wroński K. Quality of life in a 20-year follow-up study of people suffering from schizophrenia. Compr Psychiatry. 2015;56:133–40.

    Article  PubMed  Google Scholar 

  • Di Forti M, Iyegbe C, Sallis H, Kolliakou A, Falcone MA, Paparelli A, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72:811–6.

    Article  PubMed  Google Scholar 

  • Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36:48–70.

    Article  PubMed  Google Scholar 

  • Doherty JL, O’Donovan MC, Owen MJ. Recent genomic advances in schizophrenia. Clin Genet. 2012;81:103–9.

    Article  CAS  PubMed  Google Scholar 

  • Duhig M, Patterson S, Connell M, Foley S, Capra C, Dark F, Gordon A, Singh S, Hides L, McGrath JJ, Scott J. The prevalence and correlates of childhood trauma in patients with early psychosis. Aust N Z J Psychiatry. 2015;49:651–9.

    Article  PubMed  Google Scholar 

  • Elis O, Caponigro JM, Kring AM. Psychosocial treatments for future directions. Clin Psychol Rev. 2013;33:914–28.

    Article  PubMed  PubMed Central  Google Scholar 

  • European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI). Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014;40:729–36.

    Article  Google Scholar 

  • Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 1982;17:319–34.

    Article  PubMed  Google Scholar 

  • Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013;74:400–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerlinger G, Hauser M, Hert M, Lacluyse K, Wampers M, Correll CU. Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry. 2013;12:155–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ghoreishi A, Kabootvand S, Zangani E, Bazargan-Hejazi S, Ahmadi A, Khazaie H. Prevalence and attributes of criminality in patients with schizophrenia. J Inj Violence Res. 2015;7:7–12.

    PubMed  PubMed Central  Google Scholar 

  • Gilmer TP, Stefancic A, Katz ML, Sklar M, Tsemberis S, Palinkas LA. Fidelity to the housing first model and effectiveness of permanent supported housing programs in California. Psychiatr Serv. 2014;65:1311–7.

    Article  PubMed  Google Scholar 

  • Greve J, Nielsen LH. Useful beautiful minds-an analysis of the relationship between schizophrenia and employment. J Health Econ. 2013;32:1066–76.

    Article  PubMed  Google Scholar 

  • Gur RE, Loughead J, Kohler CG, Elliott MA, Lesko K, Ruparel K, et al. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch Gen Psychiatry. 2007;64:1356–66.

    Article  PubMed  Google Scholar 

  • Harrop C, Trower P. Why does schizophrenia develop at late adolescence? Clin Psychol Rev. 2001;21:241–65.

    Article  CAS  PubMed  Google Scholar 

  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13:318–78.

    Article  PubMed  Google Scholar 

  • Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, et al. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res. 2011;45:1113–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Huguelet P, Koellner V, Boulguy S, Nagalingum K, Amani S, Borras L, Perroud N. Effects of an assertive community program in patients with severe mental disorders and impact on their families. Psychiatry Clin Neurosci. 2012;66:328–36.

    Article  PubMed  Google Scholar 

  • Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51.

    Article  PubMed  Google Scholar 

  • Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43:239–57.

    Article  CAS  PubMed  Google Scholar 

  • Kirkbride JB, Errazuriz A, Croudace TJ, Morgan C, Jackson D, Boydell J, et al. Incidence of schizophrenia and other psychoses in England, 1950–2009: a systematic review and meta-analyses. PLoS One. 2012;7:e31660.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kreyenbuhl J, Buchanan R, Kelly D, Noel J, Boggs D, Fischer B, et al. The 2009 schizophrenia patient outcomes research team (PORT) psychopharmacological treatment recommendations. Int Clin Psychopharmacol. 2011;26:e54–5.

    Article  Google Scholar 

  • Krumm S, Becker T, Wiegand-Grefe S. Mental health services for parents affected by mental illness. Curr Opin Psychiatry. 2013;26:362–8.

    Article  PubMed  Google Scholar 

  • Kylmä J, Juvakka T, Nikkonen M, Korhonen T, Isohanni M. Hope and schizophrenia: an integrative review. J Psychiatr Ment Health Nurs. 2006;13:651–64.

    Article  PubMed  Google Scholar 

  • Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425–48.

    Article  PubMed  Google Scholar 

  • Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31–41.

    Article  CAS  PubMed  Google Scholar 

  • Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951–62.

    Article  CAS  PubMed  Google Scholar 

  • Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 2002;25:409–32.

    Article  CAS  PubMed  Google Scholar 

  • Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry. 2015;172:249–58.

    Article  PubMed  Google Scholar 

  • Lodge DJ, Grace AA. Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci. 2011;29:207–13.

    Article  CAS  PubMed  Google Scholar 

  • Lucksted A, McFarlane W, Downing D, Dixon L. Recent developments in family psychoeducation as an evidence-based practice. J Marital Fam Ther. 2012;38:101–21.

    Article  PubMed  Google Scholar 

  • Matthews PR, Eastwood SL, Harrison PJ. Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS One. 2012;7, e38211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163:600–10.

    Article  PubMed  Google Scholar 

  • Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry. 2009;66:811–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4–15.

    Article  CAS  PubMed  Google Scholar 

  • Niemi LT, Suvisaari JM, Haukka JK, Lönnqvist JK. Childhood predictors of future psychiatric morbidity in offspring of mothers with psychotic disorder results from the Helsinki High-Risk Study. Br J Psychiatry. 2005;186:108–14.

    Article  PubMed  Google Scholar 

  • Palmer BW, Sirkin MA, Depp CA, Glorioso DK, Jeste DV. Wellness within illness: happiness in schizophrenia. Schizophr Res. 2014;159:151–6.

    Article  PubMed  Google Scholar 

  • Rus-Calafell M, Gutiérrez-Maldonado J, Ribas-Sabaté J. A virtual reality integrated program for improving social skills in patients with schizophrenia: a pilot study. J Behav Ther Exp Psychiatry. 2014;45:81–9.

    Article  PubMed  Google Scholar 

  • Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RK, Riecher-Rössler A, et al. EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry. 2015;30:388–404.

    Article  CAS  PubMed  Google Scholar 

  • Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC. The life course of schizophrenia: age and symptom dimensions. Schizophr Res. 1997;23:15–23.

    Article  CAS  PubMed  Google Scholar 

  • Seeman P. Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets. 2006;10:515–31.

    Article  CAS  PubMed  Google Scholar 

  • Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull. 2009;35:937–48.

    Article  PubMed  Google Scholar 

  • Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2High receptors. CNS Neurosci Ther. 2011;17:118–32.

    Article  CAS  PubMed  Google Scholar 

  • Seeman MV. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treatment. 2012a;2012:796763.

    Article  PubMed  Google Scholar 

  • Seeman MV. Women and psychosis. Womens Health. 2012b;8:215–24.

    Google Scholar 

  • Selten JP, van der Ven E, Rutten BP, Cantor-Graae E. The social defeat hypothesis of schizophrenia: an update. Schizophr Bull. 2013;39:1180–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sheffield JM, Gold JM, Strauss ME, Carter CS, MacDonald III AW, Ragland JD, et al. Common and specific cognitive deficits in schizophrenia: relationships to function. Cogn Affect Behav Neurosci. 2014;14:161–74.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev. 2012;36:1342–56.

    Article  PubMed  Google Scholar 

  • Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res. 2010;116:168–72.

    Article  PubMed  Google Scholar 

  • Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull. 2014;40:181–91.

    Article  PubMed  Google Scholar 

  • Song X, Fan X, Song X, Zhang J, Zhang W, Li X, et al. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013;150:269–73.

    Article  PubMed  Google Scholar 

  • Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92.

    Article  PubMed  Google Scholar 

  • Suvisaari JM, Taxell-Lassas V, Pankakoski M, Haukka JK, Lönnqvist JK, Häkkinen LT. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull. 2013;39:1056–66.

    Article  PubMed  Google Scholar 

  • Tejkalová H, Kaiser M, Klaschka J, Stastny F. Does neonatal brain ischemia induce schizophrenia-like behavior in young adult rats? Physiol Res. 2007;56:815–23.

    PubMed  Google Scholar 

  • Van Dorn R, Volavka J, Johnson N. Mental disorder and violence: is there a relationship beyond substance use? Soc Psychiatry Psychiatr Epidemiol. 2012;47:487–503.

    Article  PubMed  Google Scholar 

  • Vargas G, Strassnig M, Sabbag S, Gould F, Durand D, Stone L, et al. The course of vocational functioning in patients with schizophrenia: Re-examining social drift. Schizophr Res Cogn. 2014;1:e41–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wykes T, Reeder C, Landau S, Everitt B, Knapp M, Patel A, Romeo R. Cognitive remediation therapy in schizophrenia randomised controlled trial. Br J Psychiatry. 2007;190:421–7.

    Article  PubMed  Google Scholar 

  • Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34:523–37.

    Article  PubMed  Google Scholar 

  • Yao L, Lui S, Liao Y, Du M, Hu N, Thomas JA, Gong Q. White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:100–6.

    Article  PubMed  Google Scholar 

  • Zhang R, Wei Q, Kang Z, Zalesky A, Li M, Xu Y, et al. Disrupted brain anatomical connectivity in medication-naïve patients with first-episode schizophrenia. Brain Struct Funct. 2015;220:1145–59.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, The Institute of Medical Science, University of Toronto, Toronto, ON, Canada

    Mary V. Seeman

Authors
  1. Mary V. Seeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary V. Seeman .

Editor information

Editors and Affiliations

  1. Psychiatry, University of Toronto, Toronto, Ontario, Canada

    A. George Awad

  2. Department of Psychiatry, University of Western Ontario, London, Ontario, Canada

    Lakshmi N.P. Voruganti

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Seeman, M.V. (2016). Schizophrenia and Its Sequelae. In: Awad, A., Voruganti, L. (eds) Beyond Assessment of Quality of Life in Schizophrenia. Adis, Cham. https://doi.org/10.1007/978-3-319-30061-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30061-0_1

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-30059-7

  • Online ISBN: 978-3-319-30061-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation